Hospitals tap BI tools for prescription drug research
Harvard Medical School and Brigham & Women’s Hospital in Boston will implement IBM business intelligence technology to support research examining the effectiveness of prescription drugs.
Harvard Medical School and Brigham & Women’s research teams are conducting pharmacoepidemiology studies that look at the effects of drugs in large numbers of people. The studies are based on insurance claims data, according to IBM, of Armonk, N.Y.
The research is designed to answer questions such as which anti-inflammatory drugs carry a risk of heart attack, what osteoporosis medications are most often used with good results or the cost-effectiveness of some drugs in treating mental health disorders.
Using an IBM Netezza data warehouse appliance, the research teams will expand their studies to analyze data from millions of de-identified patient records to develop data-intensive drug safety research methods.
Harvard Medical School and Brigham & Women’s research teams are conducting pharmacoepidemiology studies that look at the effects of drugs in large numbers of people. The studies are based on insurance claims data, according to IBM, of Armonk, N.Y.
The research is designed to answer questions such as which anti-inflammatory drugs carry a risk of heart attack, what osteoporosis medications are most often used with good results or the cost-effectiveness of some drugs in treating mental health disorders.
Using an IBM Netezza data warehouse appliance, the research teams will expand their studies to analyze data from millions of de-identified patient records to develop data-intensive drug safety research methods.